Phenolic-Enriched Ethyl Acetate Fraction of Chatuphalatika Inhibits HMG-CoA Reductase and Preferentially Improves Hepatic Metabolic Parameters in High-Fat Diet-Fed Mice
Open Access
Abstract
Chatuphalatika is a traditional Thai polyherbal formulation whose metabolically active fraction has not been identified. This study fractionated the aqueous extract (CPT) by sequential liquid–liquid partitioning to obtain solvent fractions. The ethyl acetate fraction (CPTX) had the highest total phenolic content and was enriched in hydrolyzable tannins, particularly chebulagic acid. CPTX showed the strongest inhibitory activity against HMG-CoA reductase in vitro. In vivo, C57BL/6 mice were fed a high-fat diet for 12 weeks, then treated with CPT, CPTX, or silymarin for 8 weeks while high-fat diet feeding continued. Both CPT and CPTX improved serum lipid profiles. High-dose CPTX (500 mg/kg) additionally reduced fasting blood glucose, serum ALT, and relative liver weight, without affecting body weight or adipose tissue weights. These findings indicate that phenolic enrichment concentrates the hepatic and lipid-lowering activity of Chatuphalatika. HMG-CoA reductase inhibition was used as a screening criterion to identify CPTX as the active fraction; the in vivo hepatometabolic improvements are consistent with, but do not directly confirm, modulation of cholesterol biosynthesis and hepatic lipid metabolism.Keywords
Funding Information
- Mahasarakham University (6308064)
This publication has 34 references indexed in Scilit:
- Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individualsDiabetes Research and Clinical Practice, 2022
- Hepatoprotective and anti-inflammatory potential of chebulagic acid on carbon tetrachloride–induced hepatic fibrosis by antioxidative activities in ratsComparative Clinical Pathology, 2021
- Synergistic antioxidant activity of plant compositions contained in Chatuphalathika herbal recipe: Terminalia chebula Retz. var. chebula, Terminalia arjuna Wight and Arn., Terminalia bellirica (Gaertn.) Roxb., and Phyllanthus emblica L.Advances in Traditional Medicine, 2021
- Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventionsLife Sciences, 2021
- Interaction of plant ingredients contained in Chatuphalathika herbal remedy based on chemical analysis aspect: four-component simplex lattice designAdvances in Traditional Medicine, 2020
- Effects of silymarin on metabolic syndrome: a reviewJournal of the Science of Food and Agriculture, 2018
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver diseaseCellular and Molecular Life Sciences, 2018
- Preventive effect of Terminalia bellirica on obesity and metabolic disorders in spontaneously obese type 2 diabetic model miceJournal of Natural Medicines, 2011
- Regulation of HMG-CoA reductase in mammals and yeastProgress in Lipid Research, 2011
- Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and healthFood Research International, 2011